bf/NASDAQ:SGMO_icon.jpeg

COM:SANGAMO

Sangamo Therapeutics, Inc.

  • Stock

Last Close

1.95

21/11 21:00

Market Cap

82.75M

Beta: -

Volume Today

3.28M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-25.35M
-
-42.48M
67.58%
-23.52M
44.63%
-265.50K
98.87%
-738K
177.97%
-813.50K
10.23%
-11.44M
1,306.82%
-36.52M
219.12%
-69.35M
89.88%
-44.08M
36.43%
0.50
100.00%
average payables
3.03M
-
4.27M
40.85%
4.71M
10.33%
3.24M
31.23%
1.30M
59.97%
1.69M
29.85%
5.01M
197.42%
9.61M
91.74%
11.16M
16.06%
16.09M
44.21%
18.84M
17.09%
average receivables
3.91M
-
7.14M
82.85%
6.81M
4.66%
4.01M
41.08%
4.39M
9.41%
4.32M
1.69%
21.32M
394.02%
21.93M
2.84%
6.31M
71.22%
5.42M
14.16%
2.90M
46.48%
book value per share
2.17
-
3.08
41.79%
2.76
10.52%
1.93
30.03%
2.41
24.66%
3.78
57.12%
3.86
2.09%
3.70
4.16%
2.60
29.82%
1.91
26.39%
0.48
75.14%
capex per share
-0.01
-
-0.01
20.05%
-0.03
273.02%
-0.01
69.98%
-0.05
363.01%
-0.44
824.77%
-0.18
58.49%
-0.11
40.65%
-0.16
47.13%
-0.13
18.84%
-0.12
7.21%
capex to depreciation
-0.76
-
-1.13
48.99%
-2.44
115.74%
-0.73
69.91%
-2.50
241.05%
-18.26
629.06%
-2.15
88.21%
-1.10
48.86%
-1.32
19.91%
-0.98
25.67%
-0.95
2.83%
capex to operating cash flow
0.02
-
0.11
393.49%
0.07
34.66%
0.01
84.46%
-0.34
3,120.00%
-1.16
245.46%
0.14
112.35%
-0.09
160.50%
0.10
215.22%
0.09
9.62%
0.09
4.31%
capex to revenue
-0.02
-
-0.01
24.37%
-0.06
350.41%
-0.04
38.09%
-0.10
171.71%
-0.51
397.11%
-0.20
60.42%
-0.12
38.32%
-0.21
68.91%
-0.18
13.81%
-0.12
33.76%
cash per share
1.66
-
2.67
61.04%
3.00
12.21%
2.02
32.57%
3.12
54.24%
4.13
32.47%
3.23
21.67%
4.77
47.56%
2.60
45.40%
1.80
30.94%
0.46
74.19%
days of inventory on hand
days payables outstanding
250.97
-
days sales outstanding
52.83
-
85.87
62.53%
26.11
69.60%
97.82
274.68%
35.76
63.44%
21.82
39.00%
133.95
513.98%
19.33
85.57%
20.98
8.52%
14.67
30.09%
2.75
81.27%
debt to assets
0.03
-
0.02
23.26%
0.02
-
0.09
245.29%
0.05
45.64%
0.07
48.52%
0.04
35.62%
0.07
48.53%
0.08
15.07%
0.23
200.76%
debt to equity
0.04
-
0.03
21.95%
0.03
-
0.13
354.52%
0.08
42.62%
0.10
35.83%
0.08
17.54%
0.13
51.39%
0.15
14.09%
0.46
214.55%
dividend yield
earnings yield
-0.03
-
-0.03
24.33%
-0.06
146.62%
-0.33
421.05%
-0.04
87.20%
-0.06
44.10%
-0.08
31.58%
-0.06
28.55%
-0.16
184.85%
-0.40
141.27%
-2.72
585.70%
enterprise value
767.29M
-
1.01B
32.07%
567.40M
44.01%
197.07M
65.27%
1.26B
537.08%
1.00B
20.34%
902.37M
9.78%
2.01B
122.62%
953.47M
52.54%
427.31M
55.18%
87.68M
79.48%
enterprise value over ebitda
-28.86
-
-38.50
33.40%
-12.11
68.55%
-2.72
77.57%
-22.28
720.17%
-12.96
41.80%
-8.58
33.82%
-15.51
80.74%
-5.20
66.46%
-2.12
59.18%
-0.95
55.16%
ev to operating cash flow
-39.38
-
-178.57
353.39%
-16.83
90.58%
-2.99
82.22%
112.31
3,854.58%
26.92
76.03%
-6.25
123.21%
11.83
289.24%
-4.09
134.57%
-1.91
53.26%
-0.39
79.59%
ev to sales
31.79
-
22.09
30.51%
14.35
35.04%
10.16
29.17%
34.33
237.80%
11.84
65.51%
8.81
25.61%
17.00
92.93%
8.61
49.32%
3.84
55.42%
0.50
87.04%
free cash flow per share
-0.36
-
-0.09
73.60%
-0.52
451.37%
-0.94
82.29%
0.10
110.08%
-0.06
164.12%
-1.47
2,313.94%
1.15
178.38%
-1.77
253.76%
-1.58
10.98%
-1.41
10.72%
free cash flow yield
-0.03
-
-0.01
75.89%
-0.06
818.55%
-0.31
445.68%
0.01
101.87%
-0.01
191.60%
-0.18
3,210.87%
0.07
142.04%
-0.24
419.92%
-0.50
112.62%
-2.60
415.97%
graham net net
1.02
-
1.90
85.61%
2.67
40.73%
1.77
33.81%
1.88
6.24%
1.86
1.13%
1.56
16.04%
1.34
14.21%
-0.06
104.84%
0.09
234.66%
-0.00
102.87%
graham number
4.82
-
5.23
8.40%
6.02
15.09%
6.64
10.36%
6.15
7.39%
7.74
25.89%
7.66
1.04%
8.66
12.99%
8.49
1.98%
7.32
13.77%
3.98
45.69%
income quality
0.73
-
0.21
70.64%
0.83
285.64%
0.92
10.98%
-0.20
122.28%
-0.54
163.25%
1.51
380.61%
-1.40
192.68%
1.31
193.28%
1.16
11.10%
0.87
25.02%
intangibles to total assets
0.02
-
0.01
42.09%
0.01
48.64%
0.01
37.59%
0.01
44.94%
0.16
2,808.24%
0.14
9.81%
0.11
25.83%
0.13
20.39%
0.16
21.23%
0
100%
interest coverage
21.34
-
interest debt per share
0.08
-
0.09
10.67%
0.06
-
0.32
466.59%
0.29
9.84%
0.40
38.67%
0.31
20.97%
0.33
6.25%
0.22
34.40%
0.22
0.11%
inventory turnover
invested capital
0.04
-
0.03
21.95%
0.03
-
0.13
354.52%
0.08
42.62%
0.10
35.83%
0.08
17.54%
0.13
51.39%
0.15
14.09%
0.46
214.55%
market cap
777.48M
-
1.02B
31.12%
636.88M
37.52%
215.19M
66.21%
1.28B
495.10%
1.11B
13.10%
938.39M
15.68%
2.10B
123.58%
1.08B
48.32%
484.64M
55.30%
94.78M
80.44%
net current asset value
78.15M
-
154.30M
97.45%
187.79M
21.70%
127.88M
31.90%
149.56M
16.95%
186.64M
24.80%
200.70M
7.53%
218.48M
8.86%
52.19M
76.11%
32.78M
37.20%
11.89M
63.71%
net debt to ebitda
0.38
-
0.23
40.21%
1.48
547.28%
0.25
83.16%
0.45
78.29%
1.46
228.26%
0.34
76.56%
0.69
101.14%
0.71
3.56%
0.28
60.07%
0.08
72.94%
net income per share
-0.48
-
-0.39
17.13%
-0.58
48.04%
-1.02
74.06%
-0.70
31.19%
-0.70
0.87%
-0.68
4.06%
-0.90
33.21%
-1.23
36.90%
-1.25
1.01%
-1.48
18.64%
operating cash flow per share
-0.35
-
-0.08
75.67%
-0.48
470.89%
-0.93
93.18%
0.14
115.33%
0.38
167.69%
-1.29
436.08%
1.26
198.10%
-1.61
227.70%
-1.45
10.20%
-1.29
11.04%
payables turnover
1.45
-
receivables turnover
6.91
-
4.25
38.47%
13.98
228.91%
3.73
73.31%
10.21
173.50%
16.73
63.93%
2.72
83.71%
18.88
593.02%
17.40
7.85%
24.89
43.03%
132.90
434.01%
research and ddevelopement to revenue
1.53
-
1.24
19.27%
1.70
37.39%
3.38
99.13%
1.80
46.89%
1.36
24.33%
1.42
4.74%
1.53
7.29%
2.09
36.42%
2.25
7.68%
1.31
41.76%
return on tangible assets
-0.19
-
-0.11
43.14%
-0.19
71.30%
-0.46
142.89%
-0.19
58.26%
-0.14
27.93%
-0.14
0.86%
-0.14
3.96%
-0.28
96.20%
-0.41
42.91%
-1.56
284.65%
revenue per share
0.43
-
0.68
58.74%
0.57
17.18%
0.27
51.52%
0.47
70.41%
0.87
86.03%
0.91
4.87%
0.88
3.78%
0.77
12.89%
0.72
5.83%
1.01
40.10%
roe
-0.22
-
-0.13
41.56%
-0.21
65.44%
-0.53
148.75%
-0.29
44.80%
-0.19
35.80%
-0.18
6.03%
-0.24
39.00%
-0.48
95.06%
-0.65
37.23%
-3.11
377.18%
roic
-0.21
-
-0.12
40.68%
-0.21
74.02%
-0.50
135.85%
-0.23
54.14%
-0.20
11.31%
-0.16
21.75%
-0.22
39.42%
-0.39
74.34%
-0.53
35.88%
-0.73
37.08%
sales general and administrative to revenue
0.57
-
0.34
40.23%
0.49
42.06%
1.36
179.70%
0.74
45.22%
0.55
25.60%
0.60
8.82%
0.57
5.74%
0.57
0.60%
0.56
1.38%
0.35
38.37%
shareholders equity per share
2.17
-
3.08
41.79%
2.76
10.52%
1.93
30.03%
2.41
24.66%
3.78
57.12%
3.86
2.09%
3.70
4.16%
2.60
29.82%
1.91
26.39%
0.48
75.14%
stock based compensation to revenue
0.25
-
0.20
21.25%
0.30
47.92%
0.78
161.76%
0.25
67.99%
0.17
30.08%
0.19
8.59%
0.22
15.26%
0.30
36.87%
0.28
4.48%
0.16
45.40%
tangible asset value
118.25M
-
203.18M
71.81%
190.85M
6.07%
134.61M
29.47%
186.31M
38.41%
271.61M
45.78%
340.31M
25.29%
396.44M
16.49%
281.88M
28.90%
206.68M
26.68%
82.89M
59.90%
tangible book value per share
2.11
-
3.03
43.49%
2.74
9.75%
1.91
30.27%
2.39
25.06%
2.80
17.42%
3.04
8.34%
2.95
2.86%
1.95
33.87%
1.34
31.32%
0.48
64.52%
working capital
87.14M
-
170.00M
95.08%
192.49M
13.23%
136.29M
29.20%
203.54M
49.34%
332.01M
63.12%
335.60M
1.08%
516.12M
53.79%
270.88M
47.52%
188.62M
30.37%
46.60M
75.30%

All numbers in (except ratios and percentages)